http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2394569-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e960e9cd2ff1f1ee393108b59708f877 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d0296f5f41f7b874d7d9b1bf612ed9e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_455943bf074156f53ca71183d0392a7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ce1d544f0db281452f9a31f5cb5a85 |
publicationDate | 2010-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2394569-C2 |
titleOfInvention | Application of phthalide derivatives |
abstract | FIELD: medicine. n SUBSTANCE: claimed invention relates to cemical-pharmaceutical industry and deals with phthalide derivatives, their application in production of sensibilisers or means of reversion of anti-tumour medications. Phthalide derivatives according to claimed invention can overcome or reduce polyrestance to medications, 5-30 times enhance growth inhibition caused by chemical therapeutic medications as well as considerably promote death of tumour cells caused by medications. n EFFECT: said phthalide derivatives considerably enhance sensitivity of tumour cells irrespective of anti-tumour medication type. n 10 cl, 6 ex, 6 tbl , 4 dwg |
priorityDate | 2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.